Using ESP technology, the authors found significant heterogeneity of CTCs in the blood of patients with metastatic ccRCC, which was reflected in the detection of subpopulations of CTCs expressing distinct combinations of the markers CAIX 9, EpCAM, CAXII and CK. The gene discussed is EPCAM; the disease is nonpapillary renal cell carcinoma.